Found 4 hits for monomerid = 476855 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM476855
(US10870660, Compound III-701 | US11345716, Compoun...)Show SMILES CCN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(CCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:16.17,wD:13.13,(13.28,-2.23,;11.74,-2.23,;10.97,-.9,;9.44,-.74,;9.12,.77,;10.45,1.54,;10.45,3.08,;9.12,3.85,;7.78,3.08,;7.78,1.54,;6.45,.77,;6.45,-.77,;5.12,1.54,;3.78,.77,;2.47,1.54,;1.13,.77,;1.13,-.77,;-.2,-1.54,;-1.54,-.77,;-2.87,-1.54,;-2.85,-3.08,;-4.19,-3.85,;-5.52,-3.08,;-6.98,-3.56,;-7.89,-2.31,;-9.43,-2.31,;-10.2,-.98,;-11.74,-.98,;-12.51,.36,;-12.51,-2.31,;-13.28,-.98,;-6.98,-1.06,;-5.52,-1.54,;-4.19,-.77,;2.47,-1.54,;3.8,-.77,;11.6,.51,;13.08,.91,)| Show InChI InChI=1S/C28H35F3N4O2S/c1-2-35-16-22-20(4-3-5-21(22)27(35)37)26(36)32-19-8-6-18(7-9-19)11-14-34-15-12-24-23(17-34)33-25(38-24)10-13-28(29,30)31/h3-5,18-19H,2,6-17H2,1H3,(H,32,36)/t18-,19- | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 0.150 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SHIONOGI & CO., LTD.
US Patent
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
US Patent US10870660 (2020)
BindingDB Entry DOI: 10.7270/Q2M61PBD |
More data for this Ligand-Target Pair | |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM476855
(US10870660, Compound III-701 | US11345716, Compoun...)Show SMILES CCN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(CCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:16.17,wD:13.13,(13.28,-2.23,;11.74,-2.23,;10.97,-.9,;9.44,-.74,;9.12,.77,;10.45,1.54,;10.45,3.08,;9.12,3.85,;7.78,3.08,;7.78,1.54,;6.45,.77,;6.45,-.77,;5.12,1.54,;3.78,.77,;2.47,1.54,;1.13,.77,;1.13,-.77,;-.2,-1.54,;-1.54,-.77,;-2.87,-1.54,;-2.85,-3.08,;-4.19,-3.85,;-5.52,-3.08,;-6.98,-3.56,;-7.89,-2.31,;-9.43,-2.31,;-10.2,-.98,;-11.74,-.98,;-12.51,.36,;-12.51,-2.31,;-13.28,-.98,;-6.98,-1.06,;-5.52,-1.54,;-4.19,-.77,;2.47,-1.54,;3.8,-.77,;11.6,.51,;13.08,.91,)| Show InChI InChI=1S/C28H35F3N4O2S/c1-2-35-16-22-20(4-3-5-21(22)27(35)37)26(36)32-19-8-6-18(7-9-19)11-14-34-15-12-24-23(17-34)33-25(38-24)10-13-28(29,30)31/h3-5,18-19H,2,6-17H2,1H3,(H,32,36)/t18-,19- | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 0.150 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q25T3PQ8 |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM476855
(US10870660, Compound III-701 | US11345716, Compoun...)Show SMILES CCN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(CCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:16.17,wD:13.13,(13.28,-2.23,;11.74,-2.23,;10.97,-.9,;9.44,-.74,;9.12,.77,;10.45,1.54,;10.45,3.08,;9.12,3.85,;7.78,3.08,;7.78,1.54,;6.45,.77,;6.45,-.77,;5.12,1.54,;3.78,.77,;2.47,1.54,;1.13,.77,;1.13,-.77,;-.2,-1.54,;-1.54,-.77,;-2.87,-1.54,;-2.85,-3.08,;-4.19,-3.85,;-5.52,-3.08,;-6.98,-3.56,;-7.89,-2.31,;-9.43,-2.31,;-10.2,-.98,;-11.74,-.98,;-12.51,.36,;-12.51,-2.31,;-13.28,-.98,;-6.98,-1.06,;-5.52,-1.54,;-4.19,-.77,;2.47,-1.54,;3.8,-.77,;11.6,.51,;13.08,.91,)| Show InChI InChI=1S/C28H35F3N4O2S/c1-2-35-16-22-20(4-3-5-21(22)27(35)37)26(36)32-19-8-6-18(7-9-19)11-14-34-15-12-24-23(17-34)33-25(38-24)10-13-28(29,30)31/h3-5,18-19H,2,6-17H2,1H3,(H,32,36)/t18-,19- | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 190 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q25T3PQ8 |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM476855
(US10870660, Compound III-701 | US11345716, Compoun...)Show SMILES CCN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(CCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:16.17,wD:13.13,(13.28,-2.23,;11.74,-2.23,;10.97,-.9,;9.44,-.74,;9.12,.77,;10.45,1.54,;10.45,3.08,;9.12,3.85,;7.78,3.08,;7.78,1.54,;6.45,.77,;6.45,-.77,;5.12,1.54,;3.78,.77,;2.47,1.54,;1.13,.77,;1.13,-.77,;-.2,-1.54,;-1.54,-.77,;-2.87,-1.54,;-2.85,-3.08,;-4.19,-3.85,;-5.52,-3.08,;-6.98,-3.56,;-7.89,-2.31,;-9.43,-2.31,;-10.2,-.98,;-11.74,-.98,;-12.51,.36,;-12.51,-2.31,;-13.28,-.98,;-6.98,-1.06,;-5.52,-1.54,;-4.19,-.77,;2.47,-1.54,;3.8,-.77,;11.6,.51,;13.08,.91,)| Show InChI InChI=1S/C28H35F3N4O2S/c1-2-35-16-22-20(4-3-5-21(22)27(35)37)26(36)32-19-8-6-18(7-9-19)11-14-34-15-12-24-23(17-34)33-25(38-24)10-13-28(29,30)31/h3-5,18-19H,2,6-17H2,1H3,(H,32,36)/t18-,19- | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 190 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SHIONOGI & CO., LTD.
US Patent
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
US Patent US10870660 (2020)
BindingDB Entry DOI: 10.7270/Q2M61PBD |
More data for this Ligand-Target Pair | |